Henrik Bergentoft

Insider profile

Performance

Overall performance
1.0

Performance over holding periods
1.0
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Henrik Bergentoft's trades of Oncopeptides AB's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-17 2026-03-16 B Purchase
25,020
179.80
SEK806,546
25,020 179.80 SEK806,546
2025-09-16 2025-09-16 B Purchase
4,828
14.80
SEK1,154,961
4,828 14.80 SEK1,154,961
2024-05-06 2024-05-03 B Purchase
58,097
220.79
SEK4,966,861
58,097 220.79 SEK4,966,861
2023-11-12 2023-11-10 B Purchase
10,000
7.00
SEK70,000
10,000 7.00 SEK70,000
2022-06-14 2022-06-14
SE C Rad AB (CRAD-B)
B Purchase
3,000
5.62
SEK16,860
3,000 5.62 SEK16,860
2022-05-23 2022-05-23
SE C Rad AB (CRAD-B)
B Purchase
2,200
42.30
SEK93,060
2,200 42.30 SEK93,060